Evaluating risk factors of radiation pneumonitis after stereotactic body radiation therapy in lung tumor: Meta-analysis of 9 observational studies.
<h4>Background</h4>In this study, we assessed the association of SBRT (stereotactic body radiotherapy) dose and volume with radiation pneumonitis (RP) risk in lung tumor.<h4>Methods</h4>Relevant articles were identified up to April 2018, using following databases; Medline, EM...
Main Authors: | Chi Lu, Zhang Lei, Hongbin Wu, Hongda Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0208637 |
Similar Items
-
Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Early Stage
Non-small Cell Lung Cancer
by: Lu CHEN, et al.
Published: (2014-04-01) -
Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
by: Igaki Hiroshi, et al.
Published: (2007-06-01) -
Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy
by: Taka-aki Hirose, et al.
Published: (2020-11-01) -
Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
by: Jeffrey M. Ryckman, et al.
Published: (2020-02-01) -
Correction to: Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy
by: Jeffrey M. Ryckman, et al.
Published: (2021-04-01)